Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Virology ; 438(1): 14-9, 2013 Mar 30.
Article in English | MEDLINE | ID: mdl-23415390

ABSTRACT

Classical swine fever virus (CSFV) is a positive-sense RNA virus with a high degree of genetic variability among isolates. High diversity is also found in virulence, with strains covering the complete spectrum from avirulent to highly virulent. The underlying genetic determinants are far from being understood. Since RNA polymerases of RNA viruses lack any proof-reading activity, different genome variations called haplotypes, occur during replication. A set of haplotypes is referred to as a viral quasispecies. Genetic variability can be a fitness advantage through facilitating of a more effective escape from the host immune response. In order to investigate the correlation of quasispecies composition and virulence in vivo, we analyzed next-generation sequencing data of CSFV isolates of varying virulence. Viral samples from pigs infected with the highly virulent isolates "Koslov" and "Brescia" showed higher quasispecies diversity and more nucleotide variability, compared to samples of pigs infected with low and moderately virulent isolates.


Subject(s)
Classical Swine Fever Virus/classification , Classical Swine Fever Virus/genetics , Classical Swine Fever/virology , Genetic Variation , Animals , Classical Swine Fever Virus/isolation & purification , Classical Swine Fever Virus/pathogenicity , Haplotypes , High-Throughput Nucleotide Sequencing , RNA, Viral/genetics , Swine , Virulence
2.
Virology ; 438(2): 51-5, 2013 Apr 10.
Article in English | MEDLINE | ID: mdl-23415391

ABSTRACT

Classical swine fever (CSF), a highly contagious disease of pigs caused by the classical swine fever virus (CSFV), can lead to important economic losses in the pig industry. Numerous CSFV isolates with various degrees of virulence have been isolated worldwide, ranging from low virulent strains that do not result in any apparent clinical signs to highly virulent strains that cause a severe peracute hemorrhagic fever with nearly 100% mortality. Knowledge of the molecular determinants of CSFV virulence is an important issue for effective disease control and development of safe and effective marker vaccines. In this review, the latest studies in the field of CSFV virulence are discussed. The topic of virulence is addressed from different angles; nonconventional approaches like codon pair usage and quasispecies are considered. Future research approaches in the field of CSFV virulence are proposed.


Subject(s)
Classical Swine Fever Virus/genetics , Classical Swine Fever Virus/pathogenicity , Classical Swine Fever/virology , Animals , Antibodies, Neutralizing/biosynthesis , Antibodies, Viral/biosynthesis , Classical Swine Fever Virus/immunology , Glycosylation , Swine/virology , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism , Viral Nonstructural Proteins/immunology , Viral Nonstructural Proteins/metabolism
3.
Vet Res ; 43: 33, 2012 Apr 20.
Article in English | MEDLINE | ID: mdl-22515281

ABSTRACT

Classical swine fever virus (CSFV) C-strain "Riems" escape variants generated under selective antibody pressure with monoclonal antibodies and a peptide-specific antiserum in cell culture were investigated. Candidates with up to three amino acid exchanges in the immunodominant and highly conserved linear TAV-epitope of the E2-glycoprotein, and additional mutations in the envelope proteins ERNS and E1, were characterized both in vitro and in vivo.It was further demonstrated, that intramuscular immunization of weaner pigs with variants selected after a series of passages elicited full protection against lethal CSFV challenge infection. These novel CSFV C-strain variants with exchanges in the TAV-epitope present potential marker vaccine candidates. The DIVA (differentiating infected from vaccinated animals) principle was tested for those variants using commercially available E2 antibody detection ELISA. Moreover, direct virus differentiation is possible using a real-time RT-PCR system specific for the new C-strain virus escape variants or using differential immunofluorescence staining.


Subject(s)
Antigens, Viral/immunology , Classical Swine Fever Virus/immunology , Classical Swine Fever/immunology , Enzyme-Linked Immunosorbent Assay/methods , Epitopes/immunology , Animals , Antibodies, Viral/analysis , Classical Swine Fever/virology , Classical Swine Fever Virus/genetics , Enzyme-Linked Immunosorbent Assay/veterinary , Sequence Analysis, Protein/veterinary , Swine , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/immunology
4.
Vet Microbiol ; 158(1-2): 42-59, 2012 Jul 06.
Article in English | MEDLINE | ID: mdl-22397931

ABSTRACT

Due to the tremendous socio-economic impact of classical swine fever (CSF) outbreaks, emergency vaccination scenarios are continuously under discussion. Unfortunately, all currently available vaccines show restrictions either in terms of marker capacities or immunogenicity. Recent research efforts were therefore directed at the design of new modified live marker vaccines. Among the most promising candidates the chimeric pestiviruses "CP7_E2alf" and "flc11" were identified. Within an international research project, these candidates were comparatively tested in challenge experiments after a single oral vaccination. Challenge infection was carried out with highly virulent CSF virus strain "Koslov", 14 or 21 days post vaccination (dpv), respectively. Safety, efficacy, and marker potential were addressed. All assessments were done in comparison with the conventional "gold standard" C-strain "Riems" vaccine. In addition to the challenge trials, multiple vaccinations with both candidates were performed to further assess their marker vaccine potential. All vaccines were safe and yielded full protection upon challenge 21 days post vaccination. Neither serological nor virological investigations showed major differences among the three vaccines. Whereas CP7_E2alf also provided clinical protection upon challenge at 14 days post vaccination, only 50% of animals vaccinated with flc11, and 83% vaccinated with C-strain "Riems" survived challenge at this time point. No marked differences were seen in protected animals. Despite the fact that all multiple-vaccinated animals stayed sero-negative in the accompanying marker test, the discriminatory assay remains a weak point due to delayed or inexistent detection of some of the vaccinated and subsequently infected animals. Nevertheless, the potential as live marker vaccines could be confirmed for both vaccine candidates. Future efforts will therefore be directed at the licensing of "Cp7_E2alf" as the first live marker vaccine for CSF.


Subject(s)
Classical Swine Fever Virus , Classical Swine Fever/prevention & control , Viral Vaccines/adverse effects , Viral Vaccines/immunology , Animals , Classical Swine Fever/diagnosis , Classical Swine Fever/immunology , Specific Pathogen-Free Organisms , Swine , Vaccines, Attenuated/adverse effects , Vaccines, Attenuated/immunology , Vaccines, Marker/adverse effects , Vaccines, Marker/immunology
5.
BMC Res Notes ; 4: 521, 2011 Nov 29.
Article in English | MEDLINE | ID: mdl-22126254

ABSTRACT

BACKGROUND: The genetic code consists of non-random usage of synonymous codons for the same amino acids, termed codon bias or codon usage. Codon juxtaposition is also non-random, referred to as codon context bias or codon pair bias. The codon and codon pair bias vary among different organisms, as well as with viruses. Reasons for these differences are not completely understood. For classical swine fever virus (CSFV), it was suggested that the synonymous codon usage does not significantly influence virulence, but the relationship between variations in codon pair usage and CSFV virulence is unknown. Virulence can be related to the fitness of a virus: Differences in codon pair usage influence genome translation efficiency, which may in turn relate to the fitness of a virus. Accordingly, the potential of the codon pair bias for clustering CSFV isolates into classes of different virulence was investigated. RESULTS: The complete genomic sequences encoding the viral polyprotein of 52 different CSFV isolates were analyzed. This included 49 sequences from the GenBank database (NCBI) and three newly sequenced genomes. The codon usage did not differ among isolates of different virulence or genotype. In contrast, a clustering of isolates based on their codon pair bias was observed, clearly discriminating highly virulent isolates and vaccine strains on one side from moderately virulent strains on the other side. However, phylogenetic trees based on the codon pair bias and on the primary nucleotide sequence resulted in a very similar genotype distribution. CONCLUSION: Clustering of CSFV genomes based on their codon pair bias correlate with the genotype rather than with the virulence of the isolates.

6.
J Vet Diagn Invest ; 23(5): 999-1004, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21908363

ABSTRACT

The current study reports on a real-time reverse transcription polymerase chain reaction (real-time RT-PCR) ring trial for the detection of Classical swine fever virus (CSFV) genomic RNA undertaken by 10 European laboratories. All laboratories were asked to use their routine in-house real-time RT-PCR protocols and a standardized protocol commonly used by the Friedrich-Loeffler-Institute (FLI) on a panel of well-characterized samples. In general, all participants produced results within the acceptable range. The FLI assay, several in-house assays, and the commercial kits had high analytical sensitivity and specificity values. Nevertheless, some in-house systems had unspecific reactions or suboptimal sensitivity with only a single CSFV genotype. Follow-up actions involved either improvement of suboptimal assays or replacement of specific laboratory assays with the FLI protocol, with or without modifications. In conclusion, the ring trial showed reliability of classical swine fever diagnosis on an international level and helped to optimize CSFV-specific RT-PCR diagnostics.


Subject(s)
Classical Swine Fever Virus/isolation & purification , Classical Swine Fever/diagnosis , Laboratories , Real-Time Polymerase Chain Reaction/veterinary , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Animals , Classical Swine Fever/epidemiology , Classical Swine Fever Virus/genetics , Europe , Genotype , Observer Variation , RNA, Viral/isolation & purification , Real-Time Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction/methods , Sensitivity and Specificity , Swine
7.
Vet Microbiol ; 153(3-4): 373-6, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-21684092

ABSTRACT

Oral emergency vaccination against classical swine fever is a powerful tool to control disease outbreaks among European wild boar and thus to safeguard domestic pigs in affected regions. In the past, when virus detection was mainly done using virus isolation in cell culture or antigen enzyme-linked immunosorbent assays, modified live vaccine strains like C-strain "Riems", were barely detectable after oral vaccination campaigns. Nowadays, the use of highly sensitive molecular techniques has given rise to an increase in vaccine virus detections. This was also the case during the 2009 outbreak among German wild boar and the subsequent vaccination campaigns. To guarantee a rapid differentiation of truly infected from C-strain vaccinated animals, a combination of differentiating multiplex rRT-PCR assays with partial sequencing was implemented. Here, we report on the rational and use of this approach and the lessons learned during execution. It was shown that positive results in the recently developed vaccine strain (genotype) specific rRT-PCR assay can be taken as almost evidentiary whereas negative results should be confirmed by partial sequencing. Thus, combination of multiplex rRT-PCR assays as a first line differentiation with partial sequencing can be recommended for a genetic DIVA strategy in areas with oral vaccination against classical swine fever in wild boars.


Subject(s)
Classical Swine Fever Virus/genetics , Classical Swine Fever/diagnosis , Genetic Variation , Sus scrofa , Vaccination/veterinary , Vaccines, Attenuated/genetics , Animals , Classical Swine Fever/prevention & control , Classical Swine Fever Virus/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Swine
8.
J Virol Methods ; 176(1-2): 85-95, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21703305

ABSTRACT

Amplification of natural virus isolates in permanent cell lines can result in adaptation, in particular enhanced binding to heparan sulfate (HS)-containing glycosaminoglycans present on most vertebrate cells. This has been reported for several viruses, including the pestivirus classical swine fever virus (CSFV), the causative agent of a highly contagious hemorrhagic disease in pigs. Propagation of CSFV in cell culture is essential in virus diagnostics and research. Adaptation of CSFV to HS-binding has been related to amino acid changes in the viral E(rns) glycoprotein, resulting in viruses with altered replication characteristics in vitro and in vivo. Consequently, a compound blocking the HS-containing structures on cell surfaces was employed to monitor conversion from HS-independency to HS-dependency. It was shown that the porcine PEDSV.15 cell line permitted propagation of CSFV within a limited number of passages without adaptation to HS-binding. The selection of HS-dependent CSFV mutants was also prevented by propagation of the virus in the presence of DSTP 27. The importance of these findings can be seen from the altered ratio of cell-associated to secreted virus upon acquisition of enhanced HS-binding affinity, a phenotype proposed previously to be related to virulence in the natural host.


Subject(s)
Adaptation, Physiological , Classical Swine Fever Virus/physiology , Heparitin Sulfate/metabolism , Oxadiazoles/pharmacology , Pyrimidines/pharmacology , Virus Replication , Animals , Aorta/cytology , Aorta/virology , Cell Line , Classical Swine Fever Virus/metabolism , Classical Swine Fever Virus/pathogenicity , Endothelial Cells/virology , Glycosaminoglycans/chemistry , Glycosaminoglycans/metabolism , Heparitin Sulfate/chemistry , Kidney/cytology , Kidney/virology , Oxadiazoles/chemical synthesis , Pyrimidines/chemical synthesis , Swine , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism , Viral Plaque Assay/methods , Virus Replication/drug effects
9.
J Virol Methods ; 171(1): 314-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21111760

ABSTRACT

Classical swine fever (CSF) is one of the most severe diseases of pigs, and can cause immense economic losses. Real-time reverse transcription polymerase chain reaction (rRT-PCR) can be used as a sensitive and specific method for detection of Classical swine fever virus (CSFV). Different published protocols are used routinely for CSFV diagnosis. However, almost all these systems use the highly conserved 5' untranslated region (5'UTR) of the CSFV genome as template. For a reliable diagnosis in outbreaks, a confirmatory assay that amplifies a different genome region is advisable. In this study a new CSFV specific rRT-PCR system using the NS5A region as template is described. The assay is multiplexed with a ß-actin detection system that is used as an internal control in a single tube assay. The system was validated using recent European CSFV field isolates, dilution series of an in vitro transcribed RNA standard, and a panel of RNAs representing all available Pestivirus species and genotypes. It was shown that the new assay allows reliable detection of CSFV genomes independent of the 5'UTR region. It presents a very useful diagnostic tool, also allowing a 'double check' approach to rule out 5'UTR amplicon contaminations.


Subject(s)
Classical Swine Fever Virus/isolation & purification , Classical Swine Fever/diagnosis , Reverse Transcriptase Polymerase Chain Reaction/methods , Viral Nonstructural Proteins/genetics , Virology/methods , 5' Untranslated Regions , Animals , Classical Swine Fever/virology , Classical Swine Fever Virus/genetics , DNA Primers/genetics , Reference Standards , Reverse Transcriptase Polymerase Chain Reaction/standards , Sensitivity and Specificity , Swine , Virology/standards
10.
J Gen Virol ; 91(Pt 11): 2687-97, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20660149

ABSTRACT

Classical swine fever (CSF) has caused significant economic losses in industrialized pig production, and is still present in some European countries. Recent CSF outbreaks in Europe were mainly associated with strains of genogroup 2 (subgroup 2.3). Although there are extensive datasets regarding 2.3 strains, there is very little information available on longer fragments or whole classical swine fever virus (CSFV) genomes. Furthermore, there are no detailed analyses of the molecular epidemiology of CSFV wild boar isolates available. Nevertheless, complete genome sequences are supportive in phylogenetic analyses, especially in affected wild boar populations. Here, German CSFV strains of subgroup 2.3 were fully sequenced using two different approaches: (i) a universal panel of CSFV primers that were developed to amplify the complete genome in overlapping fragments for chain-terminator sequencing; and (ii) generation of a single full-length amplicon of the CSFV genome obtained by long-range RT-PCR for deep sequencing with next-generation sequencing technology. In total, five different strains of CSFV subgroup 2.3 were completely sequenced using these newly developed protocols. The approach was used to study virus spread and evolutionary history in German wild boar. For the first time, the results of our study clearly argue for the possibility of a long-term persistence of genotype 2.3 CSFV strains in affected regions at an almost undetectable level, even after long-term oral vaccination campaigns with intensive monitoring. Hence, regional persistence in wild boar populations has to be taken into account as an important factor in the continual outbreaks in affected areas.


Subject(s)
Classical Swine Fever Virus/classification , Classical Swine Fever Virus/isolation & purification , Classical Swine Fever/epidemiology , Classical Swine Fever/virology , Sus scrofa/virology , Animals , Classical Swine Fever Virus/genetics , Cluster Analysis , DNA Primers/genetics , Evolution, Molecular , Genome, Viral , Germany/epidemiology , Molecular Epidemiology , Molecular Sequence Data , Phylogeny , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology , Vaccination/methods , Viral Vaccines/administration & dosage , Viral Vaccines/immunology
11.
J Virol Methods ; 166(1-2): 98-100, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20332004

ABSTRACT

Classical swine fever (CSF) is one of the most important diseases of pigs. Vaccination in the European Union is limited to emergency situations. Currently, vaccination for the purpose of disease control is carried out in wild boar populations. Wild boar are in most cases vaccinated using an oral bait vaccine based on the live modified vaccine virus C-strain "Riems". A real-time reverse transcription polymerase chain reaction (RT-PCR) protocol for differentiation of C-strain "Riems" vaccine virus from CSF virus (CSFV) field isolates was published previously. In this real-time RT-PCR system differentiation is based on two nucleotide difference one at the 3' end of each of the primer-binding sites in the E(RNS) encoding genome region. During extensive diagnostic use of this protocol in an outbreak of CSF in wild boar in Germany, some C-strain positive field samples were found to give negative results in the C-strain "Riems" specific real-time RT-PCR, but positive results in a pan-CSFV real-time RT-PCR system. Moreover, sequencing of C-strain "Riems" vaccine batches for intramuscular use revealed differences in the E(RNS) encoding region. This led to the assumption that mutations in the corresponding primer-binding site of the C-strain specific system had appeared in the field, and possibly also during manufacturing of different vaccine batches. To test this hypothesis and restore sensitivity, a new primer set for detection of the possible C-strain virus quasi species was designed and tested.


Subject(s)
Classical Swine Fever Virus/isolation & purification , Classical Swine Fever/diagnosis , DNA Primers/genetics , Point Mutation , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Virology/methods , Animals , Binding Sites , Classical Swine Fever/epidemiology , Classical Swine Fever/virology , Classical Swine Fever Virus/genetics , Disease Outbreaks , Germany/epidemiology , Sensitivity and Specificity , Sus scrofa/virology
12.
Vet Microbiol ; 142(1-2): 45-50, 2010 Apr 21.
Article in English | MEDLINE | ID: mdl-19892497

ABSTRACT

A new chimeric pestivirus "CP7_E1E2alf_TLA", based on the infectious cDNA of bovine viral diarrhea virus (BVDV) strain CP7, was constructed. The substitution of BVDV E1 and E2 with the respective proteins of classical swine fever (CSF) strain Alfort 187 allows an optimal heterodimerization of E1 and E2 in the chimeric virus, which is beneficial for efficient and authentic virus assembly and growth. In addition, for implementation of E2-based marker diagnostics, the previously described antigenic CSFV-specific TAVSPTTLR epitope was exchanged with the corresponding E2-epitope of BVDV strain CP7. Recombinant virus CP7_E1E2alf_TLA displayed a growth defect, and was not reacting with monoclonal antibodies used in commercial E2 antibody blocking ELISAs. Therefore, efficacy as well as marker properties of CP7_E1E2alf_TLA were investigated in an animal experiment with both a high dose and a low dose vaccine preparation. All CP7_E1E2alf_TLA-vaccinated animals seroconverted until day 28 post-vaccination with neutralizing antibodies. Furthermore, at the day of challenge infection CP7_E1E2alf_TLA-immunized animals showed distinct lower ELISA values in a commercial CSFV E2 antibody test in comparison to the C-strain vaccinated controls. However, E2-ELISA reactivity as well as neutralizing titers were directly connected to the dosage used for vaccination, and only the low dose group had E2-ELISA values below threshold until challenge infection. Following challenge infection with highly virulent CSFV strain Koslov, all vaccinees were protected, however, short-term fever episodes and very limited CSFV genome detection with very low copy numbers could be observed. In conclusion, manipulation of the TAVSPTTLR-epitope within the tested chimeric virus resulted in an slightly reduced efficacy, but the E2 marker properties unexpectedly did not allow a clear differentiation of infected from vaccinated animals in some cases.


Subject(s)
Classical Swine Fever Virus/genetics , Classical Swine Fever Virus/immunology , Classical Swine Fever/immunology , Epitopes , Viral Envelope Proteins/genetics , Viral Envelope Proteins/immunology , Viral Vaccines/immunology , Animals , Cell Line , Classical Swine Fever/prevention & control , Diarrhea Virus 1, Bovine Viral/genetics , Epitopes/genetics , Epitopes/immunology , Random Allocation , Time Factors
13.
Vet Microbiol ; 142(1-2): 13-7, 2010 Apr 21.
Article in English | MEDLINE | ID: mdl-19836906

ABSTRACT

Complete genome amplification of viral RNA provides a new tool for the generation of modified viruses. We have recently reported a full-genome amplification strategy for recovery of pestiviruses (Rasmussen et al., 2008). A full-length cDNA amplicon corresponding to the Border disease virus-Gifhorn genome was generated by long RT-PCR and then RNA transcripts derived from this amplicon were used to rescue infectious virus. Here, we have now used this full-genome amplification strategy for efficient and robust amplification of three additional pestivirus strains: the vaccine strain C and the virulent Paderborn strain of Classical swine fever virus plus the CP7 strain of Bovine viral diarrhoea virus. The amplicons were cloned directly into a stable single-copy bacterial artificial chromosome generating full-length pestivirus DNAs from which infectious RNA transcripts could be also derived.


Subject(s)
Genome, Viral/genetics , Pestivirus/genetics , Animals , Border disease virus/genetics , Cell Line , Chromosomes, Artificial, Bacterial/genetics , Classical Swine Fever Virus/genetics , Cloning, Molecular , DNA, Recombinant/genetics , Diarrhea Virus 1, Bovine Viral/genetics , Escherichia coli/genetics , Swine
14.
Vaccine ; 27(47): 6522-9, 2009 Nov 05.
Article in English | MEDLINE | ID: mdl-19732859

ABSTRACT

Due to the vast economic consequences of classical swine fever (CSF) outbreaks, emergency vaccination plans are under discussion in European Union Member States. However, animals vaccinated with the conventional C-strain vaccine are subject to trade restrictions. To ease these restrictions, potent marker vaccines are required. One promising candidate is the chimeric pestivirus CP7_E2alf. For emergency vaccination in a CSF outbreak scenario, early onset of immunity is required. Here, the studies performed with a CP7_E2alf virus stock produced under good manufacturing conditions (GMP) are reported. In challenge experiments, CP7_E2alf induced full clinical protection 1 week after intramuscular vaccination, and 2 weeks after oral immunization. Furthermore, even after application of diluted vaccine preparations complete protection could be achieved if challenge infection was carried out 4 weeks after vaccination. In conclusion, GMP-produced CP7_E2alf proved to be a suitable marker vaccine candidate - also for emergency vaccination - both after intramuscular and oral application.


Subject(s)
Classical Swine Fever Virus/immunology , Classical Swine Fever/prevention & control , Viral Vaccines/immunology , Administration, Oral , Animals , Antibodies, Viral/blood , Cell Line , Classical Swine Fever/immunology , Classical Swine Fever Virus/genetics , Injections, Intramuscular , Mutation , RNA, Viral/genetics , Sequence Analysis, RNA , Swine
15.
J Virol Methods ; 158(1-2): 114-22, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19428579

ABSTRACT

Classical swine fever (CSF) is one of the most important diseases of pigs. Although prophylactic vaccination is banned within the European Union, emergency vaccination, allowing differentiation of vaccinated from infected animals, is an option for disease control. Up to now, these strategies are based on antibody detection. In this context, conventional modified live vaccines are not suitable. A promising perspective could be genetic differentiation of vaccinated from infected animals where field virus strains are differentiated from vaccine viruses by sequence differences. This concept could also be used with marker vaccines. To this end, a set of real-time reverse transcription-polymerase chain reaction (RT-PCR) assays was developed and validated. Specific primers and probes were designed for detection of the C-strain "Riems" vaccine virus or the chimeric marker vaccine candidate CP7_E2alf. A heterologous internal positive control was also included. The assays were then multiplexed to detect simultaneously either CSF field virus, C-strain "Riems", and the internal control or CSF field virus, CP7_E2alf, and the internal control. To validate both systems, samples from vaccination/challenge trials were tested. Only samples from vaccinated animals were found to be positive, while all samples from wild type virus-infected animals and a broad test panel of different pestiviruses were negative. Field application of the "C-strain Riems" specific assay was proven with wild boar samples from surveillance programs in Germany and France. In conclusion, ready-to-use RT-PCR sets are presented as reliable tools for genetic differentiation of vaccinated from infected animals for CSFV eradication strategies.


Subject(s)
Classical Swine Fever Virus/isolation & purification , Classical Swine Fever/diagnosis , Reverse Transcriptase Polymerase Chain Reaction/methods , Viral Vaccines/genetics , Animals , Base Sequence , Classical Swine Fever/virology , Classical Swine Fever Virus/genetics , Diagnosis, Differential , European Union , Molecular Sequence Data , Oligonucleotide Probes/genetics , Sensitivity and Specificity , Sus scrofa
16.
J Virol ; 81(23): 13230-4, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17881436

ABSTRACT

The icosahedral capsid of duck hepatitis B virus (DHBV) is formed by a single core protein species (DHBc). DHBc is much larger than HBc from human HBV, and no high-resolution structure is available. In an accompanying study (M. Nassal, I. Leifer, I. Wingert, K. Dallmeier, S. Prinz, and J. Vorreiter, J. Virol. 81:13218-13229, 2007), we used extensive mutagenesis to derive a structural model for DHBc. For independent validation, we here mapped the epitopes of seven anti-DHBc monoclonal antibodies. Using numerous recombinant DHBc proteins and authentic nucleocapsids from different avihepadnaviruses as test antigens, plus a panel of complementary assays, particle-specific and exposed plus buried linear epitopes were revealed. These data fully support key features of the model.


Subject(s)
Avihepadnavirus/chemistry , Hepatitis B Virus, Duck/chemistry , Nucleocapsid/chemistry , Viral Core Proteins/chemistry , Antibodies, Monoclonal/metabolism , Antibodies, Viral/metabolism , Avihepadnavirus/immunology , Epitope Mapping , Epitopes/immunology , Hepatitis B Virus, Duck/immunology , Models, Molecular , Nucleocapsid/immunology , Protein Structure, Tertiary , Viral Core Proteins/immunology
17.
J Virol ; 81(23): 13218-29, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17881438

ABSTRACT

Duck hepatitis B virus (DHBV) shares many fundamental features with human HBV. However, the DHBV core protein (DHBc), forming the nucleocapsid shell, is much larger than that of HBV (HBc) and, in contrast to HBc, there is little direct information on its structure. Here we applied an efficient expression system for recombinant DHBc particles to the biochemical analysis of a large panel of mutant DHBc proteins. By combining these data with primary sequence alignments, secondary structure prediction, and three-dimensional modeling, we propose a model for the fold of DHBc. Its major features are a HBc-like two-domain structure with an assembly domain comprising the first about 185 amino acids and a C-terminal nucleic acid binding domain (CTD), connected by a morphogenic linker region that is longer than in HBc and extends into the CTD. The assembly domain shares with HBc a framework of four major alpha-helices but is decorated at its tip with an extra element that contains at least one helix and that is made up only in part by the previously predicted insertion sequence. All subelements are interconnected, such that structural changes at one site are transmitted to others, resulting in an unexpected variability of particle morphologies. Key features of the model are independently supported by the accompanying epitope mapping study. These data should be valuable for functional studies on the impact of core protein structure on virus replication, and some of the mutant proteins may be particularly suitable for higher-resolution structural investigations.


Subject(s)
Hepatitis B Virus, Duck/chemistry , Mutation, Missense , Viral Core Proteins/chemistry , Amino Acid Sequence , Antibodies, Monoclonal/metabolism , Antibodies, Viral/metabolism , Epitope Mapping , Hepatitis B Virus, Duck/genetics , Hepatitis B Virus, Duck/immunology , Models, Molecular , Mutagenesis , Protein Structure, Secondary , Protein Structure, Tertiary , Viral Core Proteins/genetics , Viral Core Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...